Trial Profile
Effects and health economic aspects of enzyme therapy in children and adults with Pompe disease Long-term follow-up of patients receiving commercially available Myozyme.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2011
Price :
$35
*
At a glance
- Drugs Alglucosidase alfa (Primary)
- Indications Glycogen storage disease type II
- Focus Therapeutic Use
- 23 Aug 2011 New trial record